Abstract
The gold standard to diagnose giant cell arteritis is temporal artery biopsy. The classical histologic picture of GCA is a transmural inflammatory infiltrate comprising lymphocytes, macrophages and, in about 50% of cases, giant cells. However, in some patients the inflammation may be restricted to the adventitial layer, to the vasa vasorum, or to the small vessels that surround the temporal artery.
Imaging techniques play a pivotal role both in the diagnosis and in the follow-up of patients with giant cell arteritis. According to the recommendations by the European League Against Rheumatism, imaging procedures should be the first diagnostic test, while temporal artery biopsy should be performed when imaging findings are not contributory. Color Doppler sonography is the modality of choice to image the temporal arteries: inflamed arteries typically show a positive “halo sign,” i.e., a hypoechoic (dark) halo around the temporal artery lumen. Color Doppler sonography can also be used to examine the superficial large vessels and to define whether there are lumen changes such as stenoses or aneurysms. Deep, large vessels such as the aorta are best imaged by computerized tomography or magnetic resonance imaging: signs of vasculitis are increased thickness of the vessel wall with enhancement. 18F-Fluorodeoxyglucose positron emission tomography can also be used to demonstrate arterial inflammation. 18F-Fluorodeoxyglucose positron emission tomography can visualize all large vessels and is very sensitive: a vascular smooth, linear pattern with Fluorodeoxyglucose uptake that affects long segments of the arteries is consistent with vasculitis. Imaging changes tend to improve or resolve the following treatment.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Salvarani C, Cantini F, Hunder GG. Polymyalgia rheumatica and giant-cell arteritis. Lancet. 2008;372:234–45.
Salvarani C, Cantini F, Boiardi L, Hunder GG. Polymyalgia rheumatica and giant-cell arteritis. N Engl J Med. 2002;347:261–71.
Breuer GS, Nesher R, Nesher G. Effect of biopsy length on the rate of positive temporal artery biopsies. Clin Exp Rheumatol. 2009;27:S10–3.
Narvaez J, Bernad B, Roig-Vilaseca D, et al. Influence of previous corticosteroid therapy on temporal artery biopsy yield in giant cell arteritis. Semin Arthritis Rheum. 2007;37:13–9.
Klein RG, Campbell RJ, Hunder GG, Carney JA. Skip lesions in temporal arteritis. Mayo Clin Proc. 1976;51:504–10.
Brack A, Martinez-Taboada V, Stanson A, Goronzy JJ, Weyand CM. Disease pattern in cranial and large-vessel giant cell arteritis. Arthritis Rheum. 1999;42:311–7.
Giuseppe G, Francesco M, Luca C, et al. Is colour duplex sonography-guided temporal artery biopsy useful in the diagnosis of giant cell arteritis? A randomized study. Rheumatol. (Oxford). 2015;54(3):400–4.
Cavazza A, Muratore F, Boiardi L, et al. Inflamed temporal artery: histologic findings in 354 biopsies, with clinical correlations. Am J Surg Pathol. 2014;38:1360–70.
Muratore F, Cavazza A, Boiardi L, et al. Histopathologic findings of patients with biopsy-negative giant cell arteritis compared to those without arteritis: a population-based study. Arthritis Care Res (Hoboken). 2016;68:865–70.
Lally L, Pernis A, Narula N, Huang WT, Spiera R. Increased rho kinase activity in temporal artery biopsies from patients with giant cell arteritis. Rheumatology (Oxford). 2015;54:554–8.
Dejaco C, Ramiro S, Duftner C, et al. EULAR recommendations for the use of imaging in large vessel vasculitis in clinical practice. Ann Rheum Dis. 2018;77:636–43.
Pipitone N, Versari A, Salvarani C. Role of imaging studies in the diagnosis and follow-up of large-vessel vasculitis: an update. Rheumatology (Oxford). 2008;47:403–8.
Germano G, Monti S, Ponte C, et al. The role of ultrasound in the diagnosis and follow-up of large-vessel vasculitis: an update. Clin Exp Rheumatol. 2017;35(Suppl 103):194–8.
Schmidt WA, Kraft HE, Vorpahl K, Volker L, Gromnica-Ihle EJ. Color duplex ultrasonography in the diagnosis of temporal arteritis. N Engl J Med. 1997;337:1336–42.
Rinagel M, Chatelus E, Jousse-Joulin S, et al. Diagnostic performance of temporal artery ultrasound for the diagnosis of giant cell arteritis: a systematic review and meta-analysis of the literature. Autoimmun Rev. 2019;18:56–61.
Arida A, Kyprianou M, Kanakis M, Sfikakis PP. The diagnostic value of ultrasonography-derived edema of the temporal artery wall in giant cell arteritis: a second meta-analysis. BMC Musculoskelet Disord. 2010;11:44.
Aschwanden M, Daikeler T, Kesten F, et al. Temporal artery compression sign—a novel ultrasound finding for the diagnosis of giant cell arteritis. Ultraschall Med. 2013;34:47–50.
Aschwanden M, Imfeld S, Staub D, et al. The ultrasound compression sign to diagnose temporal giant cell arteritis shows an excellent interobserver agreement. Clin Exp Rheumatol. 2015;33:S113–5.
Hauenstein C, Reinhard M, Geiger J, et al. Effects of early corticosteroid treatment on magnetic resonance imaging and ultrasonography findings in giant cell arteritis. Rheumatology (Oxford). 2012;51:1999–2003.
Bley TA, Uhl M, Carew J, et al. Diagnostic value of high-resolution MR imaging in giant cell arteritis. AJNR Am J Neuroradiol. 2007;28:1722–7.
Ghinoi A, Zuccoli G, Nicolini A, et al. 1T magnetic resonance imaging in the diagnosis of giant cell arteritis: comparison with ultrasonography and physical examination of temporal arteries. Clin Exp Rheumatol. 2008;26:S76–80.
Bley TA, Ness T, Warnatz K, et al. Influence of corticosteroid treatment on MRI findings in giant cell arteritis. Clin Rheumatol. 2007;26:1541–3.
Czihal M, Zanker S, Rademacher A, et al. Sonographic and clinical pattern of extracranial and cranial giant cell arteritis. Scand J Rheumatol. 2012;41:231–6.
Loffler C, Hoffend J, Benck U, Kramer BK, Bergner R. The value of ultrasound in diagnosing extracranial large-vessel vasculitis compared to FDG-PET/CT: a retrospective study. Clin Rheumatol. 2017;36:2079–86.
Geiger J, Bley T, Uhl M, Frydrychowicz A, Langer M, Markl M. Diagnostic value of T2-weighted imaging for the detection of superficial cranial artery inflammation in giant cell arteritis. J Magn Reson Imaging. 2010;31:470–4.
Gotway MB, Araoz PA, Macedo TA, et al. Imaging findings in Takayasu’s arteritis. AJR Am J Roentgenol. 2005;184:1945–50.
Prieto-Gonzalez S, Arguis P, Garcia-Martinez A, et al. Large vessel involvement in biopsy-proven giant cell arteritis: prospective study in 40 newly diagnosed patients using CT angiography. Ann Rheum Dis. 2012;71:1170–6.
Pipitone NAM, Versari A, Salvarani C. Usefulness of PET in recognizing and managing vasculitides. Curr Opin Rheumatol. 2018;30:24–9.
Einspieler I, Thurmel K, Pyka T, et al. Imaging large vessel vasculitis with fully integrated PET/MRI: a pilot study. Eur J Nucl Med Mol Imaging. 2015;42:1012–24.
Balink H, Houtman PM, Collins J. 18F-FDG PET versus PET/CT as a diagnostic procedure for clinical suspicion of large vessel vasculitis. Clin Rheumatol. 2011;30:1139–41.
Muratore F, Crescentini F, Spaggiari L, et al. Aortic dilatation in patients with large vessel vasculitis: a longitudinal case control study using PET/CT. Semin Arthritis Rheum. 2019;48:1074–82.
Meller J, Strutz F, Siefker U, et al. Early diagnosis and follow-up of aortitis with [(18)F]FDG PET and MRI. Eur J Nucl Med Mol Imaging. 2003;30:730–6.
Hautzel H, Sander O, Heinzel A, Schneider M, Muller HW. Assessment of large-vessel involvement in giant cell arteritis with 18F-FDG PET: introducing an ROC-analysis-based cutoff ratio. J Nucl Med. 2008;49:1107–13.
Slart RHJA. FDG-PET/CT(A) imaging in large vessel vasculitis and polymyalgia rheumatica: joint procedural recommendation of the EANM, SNMMI, and the PET Interest Group (PIG), and endorsed by the ASNC. Eur J Nucl Med Mol Imaging. 2018;45:1250–69.
Castellani M, Vadrucci M, Florimonte L, Caronni M, Benti R, Bonara P. 18F-FDG uptake in main arterial branches of patients with large vessel vasculitis: visual and semiquantitative analysis. Ann Nucl Med. 2016;30:409–20.
Belhocine T, Blockmans D, Hustinx R, Vandevivere J, Mortelmans L. Imaging of large vessel vasculitis with (18)FDG PET: illusion or reality? A critical review of the literature data. Eur J Nucl Med Mol Imaging. 2003;30:1305–13.
Besson FL, Parienti JJ, Bienvenu B, et al. Diagnostic performance of (1)(8)F-fluorodeoxyglucose positron emission tomography in giant cell arteritis: a systematic review and meta-analysis. Eur J Nucl Med Mol Imaging. 2011;38:1764–72.
Soussan M, Nicolas P, Schramm C, et al. Management of large-vessel vasculitis with FDG-PET: a systematic literature review and meta-analysis. Medicine (Baltimore). 2015;94:e622.
Lee YH, Choi SJ, Ji JD, Song GG. Diagnostic accuracy of 18F-FDG PET or PET/CT for large vessel vasculitis: a meta-analysis. Z Rheumatol. 2016;75:924–31.
Fuchs M, Briel M, Daikeler T, et al. The impact of 18F-FDG PET on the management of patients with suspected large vessel vasculitis. Eur J Nucl Med Mol Imaging. 2012;39:344–53.
Lariviere D, Benali K, Coustet B, et al. Positron emission tomography and computed tomography angiography for the diagnosis of giant cell arteritis: a real-life prospective study. Medicine (Baltimore). 2016;95:e4146.
Quinn KA, Ahlman MA, Malayeri AA, et al. Comparison of magnetic resonance angiography and (18)F-fluorodeoxyglucose positron emission tomography in large-vessel vasculitis. Ann Rheum Dis. 2018;77:1165–71.
Tso E, Flamm SD, White RD, Schvartzman PR, Mascha E, Hoffman GS. Takayasu arteritis: utility and limitations of magnetic resonance imaging in diagnosis and treatment. Arthritis Rheum. 2002;46:1634–42.
Blockmans D, De Ceuninck L, Vanderschueren S, Knockaert D, Mortelmans L, Bobbaers H. Repetitive 18F-fluorodeoxyglucose positron emission tomography in giant cell arteritis: a prospective study of 35 patients. Arthritis Rheum. 2006;55:131–7.
Blockmans D, Coudyzer W, Vanderschueren S, et al. Relationship between fluorodeoxyglucose uptake in the large vessels and late aortic diameter in giant cell arteritis. Rheumatology (Oxford). 2008;47:1179–84.
de Boysson H, Liozon E, Lambert M, et al. 18F-fluorodeoxyglucose positron emission tomography and the risk of subsequent aortic complications in giant-cell arteritis: a multicenter cohort of 130 patients. Medicine (Baltimore). 2016;95:e3851.
Kermani TA, Diab S, Sreih AG, et al. Arterial lesions in giant cell arteritis: a longitudinal study. Semin Arthritis Rheum. 2019;48:707–13.
Aschwanden M, Schegk E, Imfeld S, et al. Vessel wall plasticity in large vessel giant cell arteritis: an ultrasound follow-up study. Rheumatology (Oxford). 2019;58(5):792–7.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2021 Springer Nature Switzerland AG
About this chapter
Cite this chapter
Pipitone, N. (2021). Histopathology and Imaging. In: Salvarani, C., Boiardi, L., Muratore, F. (eds) Large and Medium Size Vessel and Single Organ Vasculitis. Rare Diseases of the Immune System. Springer, Cham. https://doi.org/10.1007/978-3-030-67175-4_5
Download citation
DOI: https://doi.org/10.1007/978-3-030-67175-4_5
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-67174-7
Online ISBN: 978-3-030-67175-4
eBook Packages: MedicineMedicine (R0)